Varex Imaging

Varex Imaging

Varex Imaging was established in January 2017 when Varian Medical Systems completed the tax-free spin-off of its imaging components business, creating a standalone public company traded on the Nasdaq under the ticker VREX. CEO Sunny Sanyal, who previously served as President of McKesson Technology Solutions, took the helm in 2019 following decades of leadership steeped in healthcare technology operations. The company remains rooted in Salt Lake City, where it manufacturers X-ray tubes, digital detectors, and imaging software that original equipment manufacturers integrate into CT scanners, mammography systems, and baggage screening equipment across the world. Varex does not deploy capital as a family office or fund manager — it operates as a vertically integrated manufacturer whose investment posture is defined by R&D expenditure and strategic acquisitions rather than third-party LP commitments. The company's product portfolio spans medical imaging tubes, solid-state flat-panel detectors, and high-voltage connectors, with approximately two-thirds of revenue historically generated from medical markets and one-third from industrial and security inspection applications. Acquisition strategy has targeted software and detector technologies that widen its component moat, demonstrated by the 2019 purchase of Direct Conversion, a Swedish-based developer of photon-counting detectors, and the 2021 acquisition of PCTEL's antenna business for industrial IoT connectivity. Geographic manufacturing and sales presence extends across North America, Europe, and Asia-Pacific, with production facilities in the United States, Germany, the Netherlands, and the Philippines (per the firm's official communications). Post-spin, Varex has operated with a workforce of approximately 2,000 to 2,300 employees globally. The firm's public-company structure means its deployment data is reported quarterly via SEC filings rather than through private market sources. August 2023 marked a board-level refresh when Varex named Kimberley D. Washburn, a former Baxter Healthcare executive, to its audit committee, signaling continued emphasis on operational governance over financial engineering. While the firm does not manage external funds or operate philanthropic foundations tied to a single-family wealth origin, its technology underpins diagnostic systems sold by Siemens Healthineers, GE HealthCare, and Philips — embedding Varex's components in a substantial portion of the world's installed base of X-ray imaging equipment. As a public manufacturer, Varex's structural distinction from family offices or allocator platforms is absolute: the business generates revenue by selling high-tolerance imaging components, not by managing third-party capital. The 2017 spin-off from Varian created a pure-play entity whose strategic decisions — R&D allocation, factory footprint, M&A — are disciplined by quarterly earnings and shareholder return expectations rather than multi-decade family capital. This public-market accountability shapes a fundamentally different risk and time-horizon profile than any single-family or multi-family office.